CYP2D6 and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, a 200 CML patient study, mostly Ph+ve, from Pakistan, showed that the prevalence of CYP2D6*4 IM in CML patients was significantly higher, whilst PM polymorphism showed no statistical association as only three out of the 200 patients carried the PM gene [46].